Recent Finacing
Recent Raise
Montis Biosciences develops immuno-oncology therapeutics that modulate tumor endothelial cell–perivascular macrophage interactions, using proprietary target-screening and assay platforms plus single-cell RNA‑seq to enhance immune infiltration.
